Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

Click for more information

2.10%

$1.17 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-92

First 92 Last

Share
Profile

Follow
dnyland

3,703 Posts.

48

02/10/20

17:09

Post #: 47818505
Share

Originally posted by stockrock: ↑

Hi

The last formal meeting that I am aware of is the late-cycle meeting, which is before the ODAC. In some cases there is a meeting after the ODAC.. but it's not always the case. MSB indicated they were going to discuss the outcomes with the FDA after the ODAC, so I assume they did have a meeting post ODAC.

In terms of the Type A meeting, this is common after getting a CRL and the meeting is expected to occur within 30 days of the FDA receiving the meeting request. Not much more to add, and while MSB are confident of a positive outcome... all companies have to say that, and given how the FDA is clearly trying to make an example of MSB as the benchmark for approval... I don't think any of us can confidently say they know what the FDA is going to do from here on in.

When the FDA is willing to go against a 9-1 ODAC vote, with a paediatric popn with a disease with 80% mortality and no other approved treatment considered standard of care... it definitely defies logic and forces me to default to a very conservative view on when MSB will get approval.

Expand

If DTs or MTs Covid situation progresses to ARDS, you can bet your boots they will be looking to MESO for treatment. Look out FDA.

MSB Price at posting: $3.19 Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Shekel Brainweigh and Calmer Co lead innovations in the retail space

There are more pages in this discussion • 926 more messages in this thread...

First 92 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.17		Change -0.025(2.10%)		Mkt cap ! $1.330B

Open	High	Low	Value	Volume
$1.18	$1.22	$1.15	$6.344M	5.404M

Buyers (Bids)

No.	Vol.	Price($)
1	8683	$1.16

Sellers (Offers)

Price($)	Vol.	No.
$1.17	32999	1

View Market Depth

No.	Vol.	Price($)
1	8683	1.155
7	295447	1.150
3	70786	1.145
6	196386	1.140
3	75486	1.135

Price($)	Vol.	No.
1.165	32999	1
1.170	62618	6
1.175	48590	3
1.180	79079	4
1.185	17090	2

Last trade - 16.10pm 15/07/2024 (20 minute delay)

MSB (ASX) Chart

SPONSORED BY